ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756304 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756304; 2) Community: the network communities that were significantly associated with the response to NSC 756304; 3) Molecule: the relationships between components within communities and NSC 756304; 4) MDR: the compounds that were significantly associated with the NSC 756304.

NSC Compound Enrichment Correlation
NSC 724781 (1S,4R,5R,8R,12R,13S)-9-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl -10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10.3.1. 04,13.08,13]hexadec-9-en-9-yl]methoxy}-2-butenyl)oxy]methyl} -1,5-dimethyl-10 0.0147237897640499 -0.20044059
NSC 748643 Mitaplatin 0.0147237897640499 -0.23929874
NSC 756407 GW853606X 0.0147237897640499 -0.18090397
NSC 757933 1,3-diphenyl-4-(3-phenyl-4,5-dihydro-1H-pyrazol-5-yl)-1H-pyrazole 0.0176693828663437 0.27751004
NSC 351907 MASTOPARAN 0.0181211508101519 -0.16206748
NSC 36768 Null 0.0181211508101519 0.01529619
NSC 372944 Null 0.0181211508101519 -0.35969157
NSC 620277 4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline 0.0181211508101519 -0.19690395
NSC 683662 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[2-(dimethylamino)-1-oxoethoxy]-19-[(2-propenyl)amino]-, stereo 0.0181211508101519 -0.25345564
NSC 702734 Null 0.0181211508101519 -0.0922106
Total:52  Current:17    [First] [Prev] [Next] [Last]